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Members of the Burkholderia cepacia complex (Bcc) are important in medical, biotech-
nological, and agricultural disciplines. These bacteria naturally occur in soil and water
environments and have adapted to survive in association with plants and animals including
humans. All Bcc species are opportunistic pathogens including Burkholderia cenocepacia
that causes infections in cystic ﬁbrosis and chronic granulomatous disease patients. The
adaptation of B. cenocepacia to the host environment was assessed in a rat chronic res-
piratory infection model and compared to that of high cell-density in vitro grown cultures
using transcriptomics. The distribution of genes differentially expressed on chromosomes
1, 2, and 3 was relatively proportional to the size of each genomic element, whereas
the proportion of plasmid-encoded genes differentially expressed was much higher rel-
ative to its size and most genes were induced in vivo. The majority of genes encoding
known virulence factors, components of types II and III secretion systems and chromo-
some 2-encoded type IV secretion system were similarly expressed between in vitro and
in vivo environments. Lower expression in vivo was detected for genes encoding N -acyl-
homoserine lactone synthase CepI, orphan LuxR homolog CepR2, zinc metalloproteases
ZmpA and ZmpB, LysR-type transcriptional regulator ShvR, nematocidal protein AidA, and
genes associated with ﬂagellar motility, Flp type pilus formation, and type VI secretion.
Plasmid-encoded type IV secretion genes were markedly induced in vivo. Additional genes
induced in vivo included genes predicted to be involved in osmotic stress adaptation or
intracellular survival, metal ion, and nutrient transport, as well as those encoding outer
membrane proteins. Genes identiﬁed in this study are potentially important for virulence
during host–pathogen interactions and may be associated with survival and adaptation to
the host environment during chronic lung infections.
Keywords: Burkholderia cenocepacia, Burkholderia cepacia complex, microarray, lung infection, rat chronic
respiratory infection model, in vitro, in vivo
INTRODUCTION
Members of the Burkholderia cepacia complex (Bcc) are com-
monly found in soil and aquatic environments (LiPuma, 2010;
Loutet andValvano, 2010). SeventeenBcc species have been identi-
ﬁed, all of which have the potential to be opportunistic pathogens,
although Burkholderia cenocepacia is the most clinically signiﬁ-
cant.B. cenocepacia causes lung infections resulting in signiﬁcantly
decreased survival rates in cystic ﬁbrosis and chronic granulo-
matous disease patients (Mahenthiralingam et al., 2005). The
organism is intrinsically multidrug resistant and can persist in
the lungs of CF patients for many years (Mahenthiralingam et al.,
2008). In some patients, infection with B. cenocepacia can progress
to what is termed “cepacia syndrome.” Cepacia syndrome is asso-
ciated with a rapid deterioration in lung function associated with
necrotizing pneumonia, bacteremia and sepsis that can result in
death (Isles et al., 1984).
Many virulence factors have been identiﬁed in B. cenocepacia
including extracellular enzymes, toxins, secretions systems, iron
acquisition systems, cell–cell communication (quorum sensing,
QS) systems, regulatory proteins as well as genes contributing
to motility, bioﬁlm formation, adhesion, cell invasion, intracel-
lular survival, and bacterial protection from host factors (for
review see Loutet and Valvano, 2010). Several infection mod-
els have been employed to identify and characterize the con-
tribution of numerous genes to pathogenesis (Uehlinger et al.,
2009). B. cenocepacia exhibits virulence against Caenorhabditis
elegans (Kothe et al., 2003), Galleria mellonella (Seed and Den-
nis, 2008), Acanthamoeba (Marolda et al., 1999), Dictyostelium
discoideum (Aubert et al., 2008), Danio rerio (Vergunst et al.,
2010), Drosophila melanogaster (Castonguay-Vanier et al., 2010),
and alfalfa seedlings (Bernier et al., 2003). Chronic respiratory
infection models have been developed in mice and rats to inves-
tigate pathogenesis of Bcc species. The rat chronic respiratory
infection model described by Cash et al. (1979) involves transtra-
cheal delivery of agar-embedded bacteria directly into the lung
allowing for bacterial persistence and pathology to be measured.
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This chronic infection model has been used to identify Bcc species
and bacterial strains that persisted or caused lung pathology from
less virulent strains such as mutants in ornibactin biosynthesis,
uptake and utilization, zinc metalloproteases, and genes encoding
other enzymes, transcriptional regulators, and lipopolysaccharide
(Sokol et al., 1999, 2000; Bernier et al., 2003, 2008; Corbett et al.,
2003; Baldwin et al., 2004; Bernier and Sokol, 2005; Kooi et al.,
2006; Loutet et al., 2006; Flannagan et al., 2007). These studies
have revealed the importance of individual genes or systems to
virulence but have not assessed bacterial gene expression during
infection.
Transcriptional proﬁling using custom B. cenocepacia microar-
rays and RNA sequencing technology have enabled in vitro gene
expression studies to be performed at a genome level. Tran-
scriptional proﬁling has been used to examine gene expression
in different environmental conditions such as those mimicking
CF sputum or soil, or in response to antimicrobials (Drevinek
et al., 2008; Yoder-Himes et al., 2009, 2010; Peeters et al., 2010;
Bazzini et al., 2011; Coenye et al., 2011; Sass et al., 2011). In
addition to further characterizing genes previously known to be
important in virulence, these studies have also identiﬁed many
genes with potential importance in virulence. Our current under-
standing of B. cenocepacia physiology, pathogenesis, and survival
is incomplete since the B. cenocepacia genome, which is over
8Mb, contains genes encoding many uncharacterized proteins.
Identifying such proteins and determining their functional sig-
niﬁcance will improve our abilities to target such proteins for
therapeutic purposes. To date, no studies have proﬁled B. ceno-
cepacia gene expression at the whole genome level directly from
infected cells/tissues or during infection of a susceptible host. To
further understand B. cenocepacia adaptation to the host environ-
ment, we have used microarrays to examine the B. cenocepacia
gene expression signature in the rat chronic respiratory infection
model and compared this to high cell-density laboratory-grown
cultures.
MATERIALS AND METHODS
BACTERIAL STRAINS AND GROWTH CONDITIONS FOR IN VITRO
SAMPLES
Burkholderia cenocepacia K56-2 is a CF isolate that belongs to
the ET12 lineage (RAPD type 2) and is clonally related to the
sequenced strain J2315 (Mahenthiralingam et al., 2000; Bald-
win et al., 2004; Holden et al., 2009). To generate in vitro sam-
ples, K56-2 cultures were grown at 37˚C, in 10ml Miller’s Luria
broth (LB; Invitrogen, Burlington, ON, Canada) with shaking in
125ml Erlenmeyer ﬂasks to stationary phase (16 h) as previously
described (O’Grady et al., 2009). Bacterial growth was assessed by
determining the optical density (OD) at 600 nm.
ANIMAL STUDIES
Animal infections were performed using the rat agar bead respi-
ratory infection model (Cash et al., 1979). Adult male Sprague-
Dawley rats (150–180 g; Charles River, QC, Canada) were inocu-
lated transtracheally with approximately 107 CFU of K56-2. At
3 days postinfection, infected lungs were aseptically removed,
stored at 4˚Covernight in 15mlof RNA later (Ambion,Streetsville,
ON, Canada), and subsequently maintained at −70˚C to prevent
RNA degradation. Animal experiments were conducted according
to the guidelines of the Canadian Council of Animal Care
for the care and use of experimental animals under protocol
M08089 approved by the University of Calgary Animal Care
Committee.
RNA MANIPULATIONS
Total RNA from in vitro samples was prepared as previously
described (O’Grady et al., 2009) using a RiboPure bacterial RNA
isolation kit according to manufacturer’s instructions (Ambion).
For in vivo samples, total RNA from infected lungs was iso-
lated using Tri Reagent (Invitrogen) as recommended by the
manufacturer. Total RNA samples were enriched for bacterial
RNA using a MicrobEnrich kit (Ambion) and puriﬁed using a
MegaClear kit (Ambion). Enriched and puriﬁed bacterial RNA
was depleted of 16S and 23S rRNAs using a MicrobExpress kit
(Ambion) to isolate mRNA according to manufacturer’s instruc-
tions to provide enhanced sensitivity for microarray experiments.
DNase treatment was performed on all RNA samples using
DNA-Free (Ambion), and samples were conﬁrmed by PCR using
Taq polymerase (Invitrogen) to be free of DNA prior to cDNA
synthesis.
MICROARRAY ANALYSIS
In vitro-derived total RNA and in vivo-derived mRNA samples
were indirectly labeled with the CyScribe Post-Labelling Kit (GE
Healthcare) and cDNA synthesis performed as described by Sass
et al. (2011) with the following modiﬁcations. Three indepen-
dent RNA samples were used for in vitro samples and two mRNA
samples (each consisting of an mRNA pool isolated from two
infected rats to reduce variability between animals) were used for
in vivo samples. Approximately 10μg total RNA was labeled for
each in vitro sample and 8μg mRNA was labeled for each in vivo
sample. The reference pool for microarray experiments consisted
of B. cenocepacia J2315 genomic DNA isolated and labeled as
described (Sass et al., 2011). The B. cenocepacia J2315 custom
microarray, with each probe printed four times using the Agi-
lent Sure Print 4× 44 microarray platform, was used (Drevinek
et al., 2008; Sass et al., 2011). Approximately 700–1000 ng labeled
cDNA from the in vitro and in vivo samples and 55 ng labeled
control genomic DNA was used per microarray. Hybridization,
washing, and scanning were performed as described using the Two
Color Microarray Based Gene Expression Analysis Protocol (Agi-
lent) and the data analyzed using GeneSpring GX version 7.3.1.
All labeling, hybridization, and scanning were performed by the
Mahenthiralingam Laboratory, Cardiff University, Wales. Initial
data were preprocessed by employing the enhanced Agilent FE
import method. Probes speciﬁc to J2315 were ﬁltered on a 1.5-
fold change in expression between conditions to identify clusters
of differentially regulated genes related to speciﬁc functions or
potentially organized in operons. To eliminate potential differ-
ences in RNA between samples, data were normalized to control
samples and mean log2 ratios (in vivo/in vitro) calculated from
replicates were used and reported as expression ratios. Mean log2
ratios were also ﬁltered on twofold changes in expression between
in vivo and in vitro conditions to identify more stringently dif-
ferentially regulated genes. The in vitro- or in vivo-derived K56-2
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cDNA produced a signal that was detected by at least 94% of
the probes on the microarray. Operon prediction and gene anno-
tation or predicted protein function were retrieved from the B.
cenocepacia J2315 genome at http://www.burkholderia.com (Win-
sor et al., 2008) or http://www.microbesonline.org (Dehal et al.,
2009). The entire microarray data set has been deposited in the
Array Express database http://www.ebi.ac.uk/arrayexpress under
accession number E-MEXP-3367.
QUANTITATIVE RT-PCR
RNA for quantitative RT-PCR (qRT-PCR) was derived indepen-
dently of that used for microarray analysis. Brieﬂy, total RNA
was isolated from three independent in vitro cultures prepared as
described above. In a separate animal experiment to that used to
prepare the microarray samples, enriched and puriﬁed total RNA
was isolated as described above from three infected rats yield-
ing three independent in vivo samples. Oligonucleotide primers
(Table 1) were designed with Primer3 (Rozen and Skaletsky, 2000)
and were synthesized by the University of Calgary Core DNA Ser-
vices (Calgary, AB, Canada). BCAL0421 (gyrB) encoding DNA
gyrase subunit B,previously used as a housekeeping gene in theBcc
multilocus sequence typing scheme (Baldwin et al., 2005)was used
as a control as described previously (Peeters et al., 2010). Expres-
sion of gyrB was not signiﬁcantly altered according to microarray
analysis (data not shown). RT-PCRwas performedusing an iScript
Select cDNA synthesis kit (Bio-Rad, Mississauga, ON, Canada).
Quantiﬁcation and melting curve analyses were performed with
SsoFast Evagreen supermix with low ROX on an iCycler (Bio-Rad)
according to manufacturer’s instructions. For each of the three
in vitro and in vivo cDNA samples, qRT-PCRs were performed in
triplicate, normalized to the control gene, gyrB. Data were calcu-
lated as previously described (Schmittgen and Livak, 2008) and
represented as fold change of the in vivo samples relative to the
in vitro samples.
RESULTS
GENES ON ALL GENOMIC ELEMENTS ARE INDUCED IN RESPONSE TO
THE HOST ENVIRONMENT
Global gene expression proﬁles were generated using microar-
rays from B. cenocepacia cultures recovered from rat lungs 3 days
postinfection using a chronic respiratory infection model and
compared to those of B. cenocepacia cultures grown to high cell-
density in vitro. Using a fold change cut off of ≥1.5, we identiﬁed
366 genes that were induced in vitro and 304 genes that were
induced in vivo (Table 2). The B. cenocepacia J2315 genome is
comprised of four genetic elements: chromosome 1, 3.87Mb;
chromosome 2, 3.22Mb; chromosome 3, 0.88Mb; and a plasmid,
0.09Mb (Holden et al., 2009).Differential expressionwas observed
for genes present on the three chromosomes as well as the plasmid.
The number of genes induced in vitro or induced in vivo on each
genomic element and the percentage of the total number of genes
induced in vitro or in vivo located on each genomic element is
shown in Table 2. For in vitro induced genes, the distribution of
changes across the genome was relatively proportional to the size
of each genomic element, i.e., a decreasing percentage of genes
showed altered expression from chromosomes 1 through 3 and to
the plasmid. Interestingly,more than 20% of genes induced in vivo
were plasmid genes indicating this group of genes was highly
overrepresented (Table 2). Consistent with this observation, for
chromosomes 1 through 3, the percentage of genes on each repli-
con induced in vivo was similar and ranged from 2.9 to 4.8%, in
marked contrast to the plasmid where 66% of plasmid-encoded
genes were induced in vivo (Table 2).
A MAJORITY OF CHARACTERIZED VIRULENCE GENES ARE SIMILARLY
EXPRESSED BETWEEN IN VITRO AND IN VIVO ENVIRONMENTS
At least 28 genes have been characterized in B. cenocepacia that
are known to be important for virulence and belong to func-
tional groups including stress resistance, extracellular enzymes or
Table 1 | Oligonucleotide primers used in this study for qRT-PCR.
Primer Sequence (5′–3′) Product size (bp) Reference
L0114ﬂiCRTfor1 GCGTGTCGATGATTCAAACGGCAT 159 O’Grady et al. (2009)
L0114ﬂiCRTrev1 TCACTTCCTGGATCTGCTGCGAAA
L0343hcpRTfor1 ACGTTCTCGCTGAAGTACGC 120 This study
L0343hcpRTrev1 CGCGTAGGTCTTGTCGTTCT
L1525qRTfor1 AGCAATCATCAAGCGTTTCC 87 This study
L1525qRTrev1 AGAGCGACTGCGATAAGTCC
M2194mmsAqRTfor1 ATGACGGTCTACACGCATGA 164 This study
M2194mmsAqRTrev1 TCGATCTCGCTCTGGAACTT
M2702prpCqRTfor1 GAAATCCAGAGCCGCTACAG 83 This study
M2702prpCqRTrev1 CCGATCACCACTTCCTTGTT
pBCA025traFqRTfor1 TCGACCTTTGCTGATACGTG 196 This study
pBCA025traFqRTrev1 GGCAGTAAGGGCAGTCAGAG
pBCA045traKqRTfor1 CGAGCCATCAAGAAGGTTGT 157 This study
pBCA045traKqRTrev1 ACTGGTAGGTAGCGCCTTGA
pBCA053qRTfor1 GCAAAGGCCGACACATCTAT 90 This study
pBCA053qRTrev1 TCTACGGGATACCGAACAGC
L0421gyrBqRTfor1 GTTCCACTGCATCGCGACTT 109 Peeters et al. (2010)
L0421gyrBqRTrev1 GGGCTTCGTCGAATTCATCA
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Table 2 | Microarray analysis of B. cenocepacia genes induced in vitro or induced in vivo.
Genomic element Total
Chr 1a Chr 2 Chr 3 Plasmid
Number of genes induced in vitro 182b 139 44 1 366
Number of genes induced in vivo 104 102 36 62 304
Percentage of total genes induced in vitro (%) 49.7c 38.0 12.0 0.3 100
Percentage of total genes induced in vivo (%) 34.2 33.6 11.8 20.4 100
Percentage of genes on each replicon induced in vitro (%) 5.1c 4.9 6.0 1.1 5.1d
Percentage of genes on each replicon induced in vivo (%) 2.9 3.6 4.8 66.0 4.2
aChr, chromosomes 1, 2, or 3 of B. cenocepacia J2315.
bNumber or cpercentage of B. cenocepacia genes or dpercentage of a total of 7210 B. cenocepacia genes exhibiting changes (≥1.5-fold) in expression in RNA recovered
from rat lungs (in vivo) relative to RNA isolated from in vitro grown cultures as determined by microarray analysis.
FIGURE 1 | In vivo expression of characterized virulence genes. Expression ratio of RNA recovered from rat lungs (in vivo) relative to RNA isolated from
in vitro grown cultures as determined by microarray analysis. The “BCA” designation has been removed from names of genes encoded on chromosomes 1, 2,
and 3 for image clarity.
secreted toxins, QS, transcriptional regulation, as well as genes
involved in heme uptake, iron acquisition, and the synthesis of
structural components such as lipopolysaccharide, porins, and
lectins (Loutet and Valvano, 2010). Analysis of these virulence
genes showed that expression of the majority of these genes was
similar between in vitro and in vivo conditions (Figure 1). The
expression of cepI, encoding anN -acyl-homoserine lactone (AHL)
synthase, was somewhat lower in vivo and this observation was
consistent with lower expression of CepIR-regulated genes includ-
ing those encoding extracellular zinc metalloproteases ZmpA and
ZmpB, the orphan LuxR homolog CepR2 and the LysR-type tran-
scriptional regulator ShvR (Figure 1). Two other genes known
to be inﬂuenced by CepIR such as the major catalase/peroxidase
encoded by katB and an acyl-CoA dehydrogenase encoded by
BCAS0208 were similarly expressed in the in vitro and in vivo
environments (Figure 1). The BCAS0208 mutant caused less lung
pathology than wild type in the rat chronic respiratory infection
model (Subramoni et al., 2011).
Limited iron availability in mammals is circumvented by infec-
tious pathogens by the production of iron binding and trans-
port complexes such as heme binding proteins and siderophores.
Although genes involved in heme transport (huvA and hmuS)
were not differentially expressed between in vivo and in vitro envi-
ronments (Figure 1), huvA mutants exhibited survival defects
in the rat chronic respiratory infection model (Hunt et al.,
2004). Genes involved in ornibactin biosynthesis and trans-
port were also expressed at similar levels in both environments,
although ornibactin mediated iron uptake is required for per-
sistence in the rat chronic respiratory infection model (Visser
et al., 2004). Among the characterized virulence genes, the low-
est in vivo expression ratio (0.04) was observed for BCAS0293
(aidA; Figure 1). The aidA gene encodes a protein that signiﬁ-
cantly contributes to virulence against C. elegans (Huber et al.,
2004), but an aidA mutation had no effect on virulence in
the rat chronic respiratory infection model (Uehlinger et al.,
2009).
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SECRETION SYSTEMS ARE SELECTIVELY REGULATED BETWEEN
IN VITRO AND IN VIVO ENVIRONMENTS
Burkholderia cenocepacia has one type II, type III, and type VI
protein secretion systems (T2SS, T3SS, and T6SS, respectively)
that contribute to pathogenesis, and two type IV secretion systems
(T4SS), one of which has been shown to be important in viru-
lence. Expression of genes encoding components of each of these
systems varied between in vitro and in vivo environments.
The T2SS is composed at least 12 ORFs on three gsp operons
and is involved in secretion of extracellular zinc metalloproteases
ZmpA,ZmpB,andother extracellular proteins that have enzymatic
activity such as phospholipase C, hemolysin, lipase, and polygalac-
turonase (Fehlner-Gardiner et al., 2002; Kothe et al., 2003;Gingues
et al., 2005; Somvanshi et al., 2010). Expression of the three gsp
operons encoding theT2SSwas similar between in vitro and in vivo
conditions (Figure 2A). Apart from the lower expression of zmpA
and zmpB in vivo (Figure 1), expression of other genes encoding
enzymes secreted by the T2SS described above was not differ-
ent between in vitro and in vivo conditions (data not shown).
The B. cenocepacia T3SS genes are organized in two operons on
chromosome 2 thought to be responsible for secretion of effec-
tor proteins that have yet to be identiﬁed (Tomich et al., 2003;
Glendinning et al., 2004). Mutation of bcscN, encoding an ATP-
bindingprotein, reducedbacterial survival, and lung inﬂammation
in a mouse agar bead infectionmodel (Tomich et al., 2003). In our
study, the mean expression ratio of genes in the bcscQ and bcscV
operons was 1.03 and 0.99, respectively, in the in vivo compared
to in vitro conditions (Figure 2B) indicating that there was no
difference in expression.
Two gene clusters located on chromosome 2 and the plasmid
have been identiﬁed to encode components of T4SS. Interestingly,
the plasmid-encoded T4SS was induced in vivo. The bc-VirB/D4
T4SS on chromosome 2 shares homology with the Agrobac-
terium tumefaciens T4SS and is involved in plasmid mobilization
FIGURE 2 | In vivo expression of genes encoding secretion
systems. Expression ratio of RNA recovered from rat lungs (in vivo)
relative to RNA isolated from in vitro grown cultures as determined by
microarray analysis. (A)T2SS, (B)T3SS, (C)T4SS, (D)T6SS. Inset in (C)
is chromosome 2-encodedT4SS genes with expanded y -axis. The
“BCA” designation has been removed from names of genes encoded
on chromosomes 1, 2, and 3 for image clarity. Putative operons are
indicated by arrows.
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(Engledow et al., 2004). The second T4SS gene cluster exists on
a 92.7-kb plasmid that is found in relatively few B. cenocepacia
strains including J2315 and K56-2 (Engledow et al., 2004) but not
AU1054 or MCO-3 (Winsor et al., 2008). This plasmid-encoded
T4SS contributes to the plant tissue watersoaking (ptw) pheno-
type and disease symptoms in onion tissue (Engledow et al., 2004)
and increased survival of B. cenocepacia in macrophages and air-
way epithelial cells (Sajjan et al., 2008). Expression of genes on the
Table 3 | Microarray and qRT-PCR analysis of selected genes showing
differential expression from in vivo compared to in vitro grown
cultures.
Gene Annotation or predicted functiona Fold changeb
microarray qRT-PCR
BCAL0114 ﬂiC, type II ﬂagellin protein −8.29 −28.00
BCAL0343 Hcp, hemolysin-coregulated
protein
−1.86 −7.82
BCAL1525 Flp type pilus subunit −11.75 −12.95
BCAM2194 mmsA,
methylmalonate-semialdehyde
dehydrogenase
2.26 1.74
BCAM2702 prpC, 2-methylcitrate synthase 5.88 8.29
pBCA025 traF, putative conjugative transfer
protein
7.10 344.86
pBCA045 traK, putative exported protein 12.43 33.26
pBCA053 Putative extracellular
solute-binding protein
480.70 10.44
aDerived from B. cenocepacia J2315 (Holden et al., 2009) at http://www.
burkholderia.com (Winsor et al., 2008) or http://www.microbesonline.org (Dehal
et al., 2009).
bFold change of RNA recovered from rat lungs (in vivo) relative to RNA isolated
from in vitro grown cultures as determined by microarray or qRT-PCR analysis.
chromosome 2-encoded T4SS were similar in the in vitro and
in vivo conditions (Figure 2C). In contrast, several genes that
are part of the plasmid-encoded T4SS were markedly induced
in vivo at levels ranging from 3- to 46.1-fold (Figure 2C). Higher
in vivo expression of pBCA025 encoding the putative conjuga-
tive transfer protein TraF and pBCA045 encoding the putative
exported protein TraK was conﬁrmed using qRT-PCR (Table 3).
These data indicated differential regulation of chromosome 2- and
plasmid-encoded T4SS between in vitro and in vivo conditions.
The B. cenocepacia T6SS comprises 16 genes organized in three
adjacent operons on chromosome 1. The T6SS contributes to sur-
vival of B. cenocepacia in the rat chronic respiratory infection
model (Hunt et al., 2004) and inﬂuences infection of macrophages
(Aubert et al., 2008). Expression of BCAL0339 and BCAL0346
was lower in B. cenocepacia growing in medium supplemented
with CF sputum compared to control cultures (Drevinek et al.,
2008). In our study, expression of six T6SS genes was lower in vivo
compared to in vitro conditions. The BCAL0340–0348 operon
exhibited the lowest expression in vivo (0.66) compared to the
other two T6SS operons (Figure 2D). The BCAL0340 operon
includes genes encoding the ClpV-like chaperone (BCAL0347)
and the hemolysin-coregulated protein (Hcp) (BCAL0343;Aubert
et al., 2008). The ClpV-like chaperone is required for secretion of
Hcp in Pseudomonas aeruginosa (Mougous et al., 2006). The hcp
gene showed the lowest in vivo expression (0.54) of any T6SS gene
and the low hcp expression in vivo was conﬁrmed using qRT-PCR
(Figure 2D; Table 3).
MOTILITY AND Flp TYPE PILUS-ENCODING GENES ARE INDUCED
IN VITRO
Bacterial motility, attachment, and invasion via ﬂagellar- and
pilus-encoding genes are known to be important in virulence
(Tomich et al., 2002; Urban et al., 2004). Expression of 24 ﬂagellar-
associated genes from eight different operons distributed across
chromosome 1 was lower in vivo, with the lowest in vivo/in vitro
FIGURE 3 | In vivo expression of motility and pilus genes. Expression ratio
of RNA recovered from rat lungs (in vivo) relative to RNA isolated from in vitro
grown cultures as determined by microarray analysis. (A) Flagellar-associated
genes, (B) Flp type pilus genes. The “BCA” designation has been removed
from names of genes encoded on chromosomes 1, 2, and 3 for image clarity.
Putative operons are indicated by arrows.
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expression ratio (0.23) observed for ﬂiC, encoding type II ﬂa-
gellin (Figure 3A). Lower expresssion of ﬂiC in vivo compared to
in vitro conditions was independently conﬁrmed using qRT-PCR
(Table 3).
The genomic locus fromBCAL1520–1537 encodes components
of a subclass of type IVb prepilins, called a Flp type pilus, that
is similar to the ﬂp–tad–rcp locus that is involved in adherence
and bioﬁlm formation in Actinobacillus actinomycetemcomitans
(Kachlany et al., 2001; Inoue et al., 2003) and aggregation and
bioﬁlm formation in P. aeruginosa (de Bentzmann et al., 2006).
Ten genes encoding components of the chromosome 1-encoded
Flp type pilus had lower in vivo expression. The lowest expression
was observed for BCAL1525 encoding a Flp type pilus subunit and
this trend was conﬁrmed using qRT-PCR (Figure 3B; Table 3).
IDENTIFICATION OF GENES POTENTIALLY IMPORTANT IN THE HOST
ENVIRONMENT
Approximately 300 genes were identiﬁed with at least a 1.5-fold
change increase in expression in vivo compared to in vitro grown
cultures (Table A1 in Appendix). Selected genes and their fold
change differences are shown in Table 4. Many of these genes
have not been previously characterized inB. cenocepacia. Themost
common putative functions of these in vivo induced genes were
related to adaptation to stress or a host environment, metabolism,
or nutrient acquisition (Table 4).
NOVEL GENES INDUCED IN VIVO
A four gene operon (BCAM2703–2700) containing genes involved
in the methylcitrate cycle, required for propionyl-CoA metabo-
lism, and fatty-acid utilization, were markedly induced in vivo
(Table 4). Induced in vivo expression of BCAM2702 (prpC)
encoding 2-methylcitrate synthase was conﬁrmed using qRT-PCR
(Table 3). Genes involved in the methylcitrate and glyoxylate
cycles are required for virulence in Mycobacterium tuberculosis,
which relies more on fatty acids than carbohydrates during infec-
tion (Munoz-Elias and McKinney, 2005). Genes involved in the
methylcitrate cycle are upregulated in M. tuberculosis isolated
from murine macrophages (Schnappinger et al., 2003) and are
important for growth in macrophages but not for intracellu-
lar survival (Munoz-Elias et al., 2006). It is unknown whether
the methylcitrate cycle plays a role in B. cenocepacia intracellular
survival in macrophages. An uncharacterized seven gene operon
(BCAM2196–BCAM2191) containing genes putatively involved
in lipid metabolism was also induced in vivo (Table 4), suggest-
ing that fatty-acid metabolism or utilization may be important
in B. cenocepacia lung infections. Using qRT-PCR we conﬁrmed
expression of BCAM2194 (mmsA) encoding methylmalonate-
semialdehyde dehydrogenase was induced in vivo (Table 3). A
four gene operon (BCAL1212–1215) induced in vivo encodes
genes for a 2-oxo acid dehydrogenase complex (Table 4). The
dihydrolipoamide dehydrogenase gene component of a similar
complex was shown to be important for persistence and virulence
in Streptococcus pneumoniae infection models likely due to having
a role in capsule synthesis rather than metabolism of 2-oxo acids
(Smith et al., 2002).
BCAM0415 encodes a betaine aldehyde dehydrogenase
(BADH; Table 4). In P. aeruginosa, BADH has been shown to
Table 4 | Selected genes induced during chronic lung infection.
Gene Annotation or predicted functiona Fold changeb
OSMOTIC STRESSANDADAPTATION
BCAL1103 Putative OsmB-like lipoprotein 2.1
BCAL2044 LdcA LD-carboxypeptidase A 1.5
BCAL2558 Pyridine nucleotide-disulﬁde
oxidoreductase
2.1
BCAL3297 DPS-family DNA-binding ferritin like
protein
1.7
BCAL3310 YceI family protein, osmotic, and acid
stress adaptation
1.7
BCAL3311 YceI family protein, osmotic, and acid
stress adaptation
1.6
BCAL3314 PqiA paraquat inducible protein A 2.4
BCAL3362 Putative oxidoreductase 1.8
BCAM0027 PadR family regulatory protein, phenolic
acid induced stress response
1.5
BCAM0414 Conserved hypothetical protein 2.0
BCAM0415 Putative betaine aldehyde dehydrogenase 1.5
BCAM2700 prpF, putative membrane protein 1.8
BCAM2701 acnA, aconitate hydratase 1 2.7
BCAM2702 prpC, 2-methylcitrate synthase 5.9
BCAM2703 prpB, probable methylisocitrate lyase 2.8
METAL IONTRANSPORT OR METABOLISM
BCAL0269 Oxidoreductase, molybdopterin-binding
domain
1.6
BCAL0366 Nitroreductase family protein, metal ion
oxidation
1.6
BCAL0580 Putative chromate transport protein 1.6
BCAL1789 ExbB, iron-transport protein 1.7
BCAL2485 Putative iron–sulfur cluster-binding
electron
2.1
BCAL2486 Putative iron–sulfur oxidoreductase 2.1
BCAM0447 Putative exported multicopper oxidase 13.0
BCAM1187 TonB-dependent siderophore receptor 1.7
BCAM1527 Putative cation efﬂux protein 1.8
BCAM2007 TonB-dependent siderophore receptor 1.6
BCAS0028 Succinylglutamate
desuccinylase/aspartoacylase
2.8
BCAS0449 Nickle ion binding-protein-dependent
transport
1.6
CARBOHYDRATETRANSPORTAND METABOLISM
BCAL0804 N -acetylglucosamine transferase 1.5
BCAL1657 Putative ribose transport system 1.8
BCAL1658 Putative ribose ABC transporter
ATP-binding
1.5
BCAL1754 Major facilitator superfamily protein,
carbohydrate transport
3.5
BCAL2040 Polysaccharide deacetylase, carbohydrate
transport
1.5
BCAL3038 ABC transporter ATP-binding component,
carbohydrate ABC transporter
1.6
BCAL3039 ABC transporter, membrane permease 1.5
BCAL3040 ABC transporter, membrane permease 1.7
(Continued)
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Table 4 | Continued
Gene Annotation or predicted functiona Fold changeb
BCAL3041 MalE, maltose-binding protein 2.1
BCAL3364 Putative gluconokinase 1.7
BCAM0094 Xylulose kinase 1.7
BCAM1330 Cellulose polysaccharide export protein 1.7
BCAM1333 Cellulose exopolysaccharide
acyltransferase
1.6
BCAM1390 Putative aldolase 3.0
BCAM2260 Major facilitator superfamily protein 1.6
BCAS0230 Putative sugar ABC transporter
ATP-binding
1.6
AMINOACIDTRANSPORTAND METABOLISM
BCAL0446 Putative aminotransferase 2.9
BCAL1212 bkdA1, 2-oxoisovalerate dehydrogenase
alpha subunit
3.0
BCAL1213 bkdA2, 2-oxoisovalerate dehydrogenase
beta subunit
2.9
BCAL1214 bhdB, lipoamide acyltransferase 3.7
BCAL1215 lpdV, dihydrolipoamide dehydrogenase 2.2
BCAL1749 Putative CoA-transferase 2.4
BCAL1750 Conserved hypothetical protein, pyruvate
decarboxylase
2.4
BCAL1751 Glyoxalase/bleomycin resistance, amino
acid transport
1.7
BCAM0047 Lysine exporter – LysE/YggA 2.6
BCAM0178 ABC transporter periplasmic
solute-binding protein
2.7
BCAM0368 Putative branched-chain amino acid
transport
1.5
BCAM0459 Cysteine desulfurase 3.6
BCAM0983 leuC1, 3-isopropylmalate dehydratase
large subunit
2.9
BCAM0983A Putative entericidin B-like bacteriolytic
toxin
2.0
BCAM0984 leuD1, 3-isopropylmalate dehydratase
small subunit
2.1
BCAM1150 3-Hydroxyisobutyrate dehydrogenase 1.6
BCAM1151 Methylmalonate-semialdehyde
dehydrogenase
2.4
BCAM1427 LysE family transporter 3.7
BCAM1487 Putative ABC transporter,
substrate-binding
3.1
BCAM1488 Putative proline racemase 1.9
BCAM2095 Putative HTH transcriptional regulator 1.6
BCAM2096 puuB gamma-glutamylputrescine
oxidoreductase
1.9
BCAM2191 Enoyl-CoA hydratase/isomerase family 1.9
BCAM2192 Enoyl-CoA hydratase/isomerase family
protein
2.4
BCAM2193 mmsB, 3-hydroxyisobutyrate
dehydrogenase
2.4
BCAM2194 mmsA, methylmalonate-semialdehyde
dehydrogenase
2.3
Gene Annotation or predicted functiona Fold changeb
BCAM2195 Putative AMP-binding enzyme 2.5
BCAM2196 Putative acyl-CoA dehydrogenase 2.1
BCAM2237 Putative 2,2-dialkylglycine decarboxylase 2.4
BCAS0397 Metallo peptidase, subfamily M20D 2.0
BCAS0443 Putative binding-protein-dependent
transport
5.3
BCAS0574 Amino acid ABC transporter ATP-binding
protein
3.7
BCAS0575 Putative binding-protein-dependent
transport
2.0
BCAS0577 Periplasmic solute-binding protein 1.5
MEMBRANE PROTEINS
BCAL0403 Putative outer membrane-bound lytic
murein
1.5
BCAL0624 Putative OmpC, outer membrane porin
protein precursor
1.6
BCAL1678 Putative outer membrane usher protein
precursor, ﬁmD pilin biogenesis
2.4
BCAL2083 YaeT, Outer membrane protein assembly
factor
1.5
BCAL2191 Putative 17 kDa membrane protein
surface antigen
3.1
BCAL2468 Putative membrane protein 1.9
BCAL2482 Putative OmpC outer membrane protein 3.1
BCAL2505 Putative membrane protein 1.5
BCAL2552 Putative membrane protein 1.5
BCAL2553 Putative membrane protein 1.8
BCAL3033 Probable outer membrane lipoprotein
carrier
1.5
BCAL3203 Putative periplasmic TolB protein 1.6
BCAL3204 Putative OmpA family lipoprotein/PAL 1.7
BCAL3205 YbgF,Tol-PAL system protein 1.6
BCAL3473 Putative OmpC-like outer membrane
porin
1.9
BCAM0926 Multidrug efﬂux system transporter
protein
5.9
BCAM1207 ABC transporter ATP-binding membrane
protein
1.5
BCAM1341 Acyltransferase like protein 3.2
BCAM1425 Putative membrane protein 2.9
BCAM1563 ABC transporter ATP-binding membrane
protein
1.7
BCAM1946 Putative quinoxaline efﬂux system
transporter
1.6
BCAM1957 ABC transporter ATP-binding protein 1.6
BCAM2647 Putative membrane protein 1.7
BCAM2648 NAD dependent epimerase/dehydratase
family, outer membrane biogenesis
1.6
BCAS0308 Putative ﬂp type pilus assembly protein,
TadG-like pilus
2.4
BCAS0463 Putative membrane protein 1.6
pBCA010 Putative membrane protein 3.2
(Continued)
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Table 4 | Continued
Gene Annotation or predicted functiona Fold changeb
pBCA014 Putative membrane protein 3.3
pBCA019 Putative membrane protein 2.4
pBCA026 Putative membrane protein 10.6
pBCA029 Putative membrane protein 8.6
pBCA034 Putative membrane protein 6.0
pBCA036 Putative membrane protein 13.8
pBCA037 Putative membrane protein 7.3
pBCA048 Putative membrane protein 55.6
EXPORTED PROTEINS
BCAL0305 Putative exported protein 2.2
BCAL0623 Putative exported protein 1.7
BCAL1279 Putative exported protein 1.6
BCAL1499 Putative exported protein 1.8
BCAL1539 Putative exported protein 2.3
BCAL1798 Putative exported protein 1.9
BCAL1961 Putative exported protein 1.9
BCAL2187 Putative exported protein 1.6
BCAL2607 Putative exported protein 2.7
BCAL2615 Putative exported outer membrane porin
protein
2.2
BCAL2911 Proline-rich exported protein 1.6
BCAL2956 Putative exported protein 1.5
BCAL3024 Putative exported protein 1.6
BCAL3490 Putative exported protein 2.0
BCAL3492 Putative exported protein 1.6
BCAM0676 Putative exported protein 1.8
BCAM1726 Putative exported protein 2.0
BCAM1742 Putative exported protein 1.9
BCAM1964 Putative exported protein 1.6
BCAM2073 Putative exported protein 3.0
pBCA013 Putative exported protein 6.3
REGULATORY PROTEINS
BCAL2488 LysR family regulatory protein 2.0
BCAL2529 LysR family regulatory protein 1.5
BCAL3486 ecfM, RNA polymerase sigma factor,
sigma-70
1.8
BCAM0422 LuxR superfamily regulatory protein 1.9
BCAM0595 LysR family regulatory protein 2.6
BCAM2025 Sigma-54 interacting regulatory protein 1.9
BCAM2162 MarR family regulatory protein 2.0
BCAS0436 AraC family regulatory protein 1.7
pBCA035 GntR family regulatory protein 18.9
aDerived from B. cenocepacia J2315 (Holden et al., 2009) at http://www.
burkholderia.com (Winsor et al., 2008) or http://www.microbesonline.org (Dehal
et al., 2009).
bFold change of RNA recovered from rat lungs (in vivo) relative to RNA isolated
from in vitro grown cultures as determined by microarray analysis.
be induced by choline and choline precursors (Velasco-Garcia
et al., 2006a) which are abundant in infected lung tissues (Wright
and Clements, 1987). In addition to playing a role in assimilat-
ing carbon and nitrogen from choline, BADH produces glycine
betaine which can protect bacteria from high osmolarity stress
and oxidative stress in infected tissues. BADH has been proposed
as a therapeutic target for P. aeruginosa since inactivation of this
enzyme leads to intracellular accumulation of betaine aldehyde,
which is toxic, and the inability to grow in medium with choline
(Velasco-Garcia et al., 2006b; Zaldivar-Machorro et al., 2011).
Homologs of other genes induced by osmotic stress in bacteria
were also identiﬁed as being induced in vivo (Table 4). BCAL1103,
encodes an OsmB-like protein. OsmB is induced by osmotic stress
and stationary phase growth conditions in E. coli (Jung et al.,
1990; Boulanger et al., 2005). BCAL3310 and BCAL3311 are pre-
dicted to be co-transcribed YceI family proteins, homologs of
which have been shown to be induced in response to osmotic
stress in E. coli (Weber et al., 2006) and acid stress in Helicobac-
ter pylori (Sisinni et al., 2010). BCAL2558, a putative pyridine
nucleotide-disulﬁde oxidoreductase with some similarity to TrxB
(thioredoxin reductase) homologs, was induced twofold in vivo.
TrxB genes are involved in cellular redox processes and defense
against oxidative stress and are important in intracellular survival
in somepathogens (Bjur et al., 2006; Potter et al., 2009). BCAL3314
encodes a homolog of PqiA-like proteins, which are induced by
paraquat and other superoxide generators in E. coli (Koh and Roe,
1995). BCAL3297 encodes a DPS-family DNA-binding ferritin.
Homologs of these proteins are involved in resistance as well as
iron sequestration (Calhoun and Kwon, 2011).
Althoughmany of the in vivo induced outer membrane protein
encoding genes are uncharacterized, a few have homology to pro-
teins with predicted functions. BCAL3203, L3204, and L3205 form
part of the Tol-PAL systemmembrane complex that is required for
membrane integrity and has been implicated in the pathogenesis
of several Gram-negative bacteria (Bowe et al., 1998; Godlewska
et al., 2009; Paterson et al., 2009). TolB (BCAL3203) is a periplas-
mic protein involved in biopolymer transport. BCAL3205 is a
YbgF homolog which is the last gene of the Tol-PAL complex
and interacts with TolA (Krachler et al., 2010). BCAL3204 has
been annotated as OmpA/PAL. PAL has been shown to contribute
to virulence in several Gram-negative bacteria and in E. coli has
been shown to be released into the bloodstream contributing to
septic shock (Hellman et al., 2002; Liang et al., 2005). A 17 kDa
OmpA-like protein has recently been shown to be an immun-
odominant antigen following intranasal immunization with a B.
cenocepacia outer membrane protein preparation in mice (Maki-
don et al., 2010). Although the immunoreactive protein reported
to be an OmpA-like protein was not conclusively identiﬁed, the
partial amino acid sequence determined from a peptide of this
molecularmass isolated from SDS-polyacrylamide gels, has 95.8%
identity to BCAL3204. There are at least six other OmpA-like pro-
teins in B. cenocepacia with varying degrees of sequence identify;
however, PAL has been shown to highly immunogenic in other
bacteria (Godlewska et al., 2009). Therefore it is possible that the
immunodominant antigen identiﬁed by Makidon et al. (2010) is
PAL. BCAL2191, which was increased threefold in vivo (Table 4)
is predicted to be an outer membrane lipoprotein with similar-
ity to 17 kDa surface antigens in other species and therefore it is
also possible that this protein contributed to the observed reac-
tion with antiserum on Western blots in the study by Makidon
et al. (2010). Several other proteins involved in biogenesis of
membrane and other cell surface components were also identiﬁed
(Table 4) including BCAL2083, a YaeT homolog, which in E.
coli is an essential gene required for outer membrane assembly
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(Werner and Misra, 2005). BCAL2482 is a putative outer mem-
brane porin (OmpC) and is in the same predicted operon as
BCAL2486 and BCAL2485, which are iron–sulfur oxidoreductase
and iron–sulfur electron transport proteins, respectively. All three
genes are induced at least twofold in vivo (Table 4).
Although ornibactin biosynthesis and uptake genes were
expressed at similar levels in the in vitro and in vivo conditions
used in this study, a number of other genes potentially involved
in metal ion transport and metabolism were identiﬁed as being
induced in vivo (Table 4). These included exbB, genes coding
for iron–sulfur proteins and receptors for unknown siderophores.
One of the most highly induced genes in vivo was BCAM0447
which encodes a putative multicopper oxidase (MCO). MCO
genes are found in a number of genomes but have only recently
been characterized. The MCO protein of P. aeruginosa has been
shown to be involved in the oxidation of ferrous to ferric iron and
may be important in iron acquisition (Huston et al., 2002). MCO
homologs are also involved in copper resistance and dissemina-
tion in mice in S. typhimurium (Achard et al., 2010) and copper
tolerance in Campylobacter jejuni (Hall et al., 2008).
Genes encoding proteins of unknown function induced in vivo
are shown in Table 4 and Table A1 in Appendix. Many of
the expressed genes encode outer membrane proteins (11) and
exported proteins (24) that could contribute to cell surface alter-
ations or virulence. Genes encoding six hypothetical proteins were
unique toB. cenocepacia (TableA1 inAppendix),whereas,23 genes
encoding hypothetical proteins were conserved in one or more
members of the Bcc, of which 11 were also conserved in Burk-
holderia pseudomallei (Table A1 in Appendix). It is possible that
these proteins are involved in adaptation, survival, or virulence in
lung infections although further studies are required to determine
their potential importance.
PLASMID-ASSOCIATED GENES
Interestingly, the most highly induced genes in vivo were located
on the plasmidwhere the vastmajority of the genes were expressed
at much higher levels in vivo than in vitro (Figure 4). Of the plas-
mid genes annotated in the J2315 sequence (Winsor et al., 2008),
62 genes had higher expression in the lung infection model. Only
one gene, pBCA055, had higher expression levels in vitro, and the
following genes had similar expression: pBCA003–007, 061, 063,
064, 066–075, 078–081, 083–086, 091–094.
FIGURE 4 | In vivo expression of plasmid-encoded genes. Expression
ratio of RNA recovered from rat lungs (in vivo) relative to RNA isolated from
in vitro grown cultures as determined by microarray analysis. The “pBCA”
designation has been removed from names of plasmid-encoded genes for
image clarity. Putative operons are indicated by arrows.
Many of the highly induced genes are part of the plasmid-
encoded T4SS, which has been shown to play a role in both plant
pathogenesis and survival in eukaryotic cells (Engledow et al.,
2004; Sajjan et al., 2008). Expression ratios of genes known or
predicted to be a part of the T4SS are shown in Figure 2C and
described above. The presence of the plasmid-encoded T4SS in
the B. cenocepacia ET12 lineage strains J2315 and K56-2 but not
AU1054 or MCO-3 that entirely lack a plasmid is an interesting
characteristic. Gene expression of pBCA054 encoding a LuxR fam-
ily regulatory protein was higher in vivo. Interestingly, the most
closely related pBCA054 orthologs are found in B. pseudomallei
and Burkholderia mallei, rather than in other members of the
Bcc. pBCA001–002 are parAB-like homologs that are putatively
involved in chromosome partitioning. pBCA017 is similar to the
zeta toxin family of toxin–antitoxin complexes which are involved
in programmed cell death to prevent proliferation of plasmid
free cells (Gerdes et al., 2005). In addition to plasmid mainte-
nance, toxin–antitoxin pairs can also be involved in responding
to nutrient stress. Zeta toxins have recently been shown to tar-
get peptidoglycan synthesis triggering autolysis (Mutschler et al.,
2011). Zeta toxins are typically paired with epsilon antitoxins;
however, there does not appear to be an epsilon homolog adjacent
to pBCA017. In some cases, a chromosomal antitoxin can neu-
tralize the plasmid toxin, but in this case toxin expression would
not favor plasmid maintenance (Van Melderen and Saavedra De
Bast, 2009). Alternatively the toxin can be integrated into other
regulatory networks or serve to reduce the overall population to
increase nutrient availability for the survivors. Three genes form-
ing an operon (pBCA053–051) exhibited the highest induction of
any groupof genes in vivo (Figure 4). pBCA053 encodes a extracel-
lular solute-binding protein involved in dicarboxylate transporter
carbohydratemetabolism andwe conﬁrmed higher in vivo expres-
sion of this gene using qRT-PCR (Table 3). The second and third
genes in the operon encode an exported protein and a protein with
homology to LamB/YcsF family proteins, respectively. In addition
to the hypothetical proteins noted above, four putative exported
proteins, nine putative membrane proteins, 12 conserved hypo-
thetical proteins and 10 hypothetical proteins encoded on the
plasmid were induced in vivo (Table A1 in Appendix). Few genes
on this plasmid have been studied in detail opening the possibility
for identifying proteins with potentially novel functions.
DISCUSSION
In this study,we have identiﬁed the gene expression signature of B.
cenocepacia during lung infections. To the best of our knowledge,
this is the ﬁrst study to apply transcriptomics for any member of
the Bcc to study gene expression during infection of a susceptible
host. Differential gene expression was observed for characterized
virulence genes as well as potential novel virulence genes between
in vitro and in vivo environments.
Altered in vivo gene expressionwas observed for genes encoding
enzymes, regulators, structural appendages as well as those con-
tributing to ornibactin biosynthesis, and quorum sensing systems.
Lower in vivo expression was observed for AHL-dependent QS
controlled genes that are directly (e.g., aidA) and indirectly (e.g.,
shvR) regulated at the transcriptional level by CepR (Weingart
et al., 2005; O’Grady et al., 2011). These observations suggest that
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more favorable conditions exist for CepIR-dependent regulation
of selected genes in high cell-density (∼109) laboratory-grown
cultures compared to the lower cell-density (∼105) in the lung
infections, although it is possible that higher expression of QS reg-
ulated genes occurs in selected locations in the lungswhere bacteria
are present in high cell-density bioﬁlms. Since cepI and CepR-
regulated genes including zmpA, zmpB, and shvR have been shown
to be important for virulence in the rat chronic respiratory infec-
tionmodel (Corbett et al., 2003; Sokol et al., 2003; Kooi et al., 2006;
Bernier et al., 2008), it is clear that these genes are expressed at sufﬁ-
cient levels to play a role in infection. Themajority of characterized
virulence genes were similarly expressed in the in vivo and in vivo
conditions. This suggests that expression of these genes is just as
important in high cell-density cultures and during lung infections.
The contribution of these individual genes has been characterized
in one or more infection models highlighting their importance in
B. cenocepacia pathogenesis. Similar expression of characterized
virulence genes during growth in vivo in hamsters and in vitro
has previously been observed for B. pseudomallei (Tuanyok et al.,
2006).
Increased expression of some genes belonging to the T3SS was
observed in the closely related pathogens B. mallei and B. pseudo-
mallei during infection of mice and hamsters, respectively (Kim
et al., 2005;Tuanyok et al., 2006). In the present study,expressionof
T2SS and T3SS genes was similar between in vitro and in vivo envi-
ronments. Genes in these secretion systems appear to be expressed
at moderate levels in both in vitro and in vivo environments. We
previously showed expression of the T2SS genes gspC and gspG
was inﬂuenced by growth medium composition (O’Grady et al.,
2011). A previous study was not able to identify growth condi-
tions that altered expression of T3SS genes suggesting these genes
are constitutively expressed (Engledow et al., 2004). The in vivo
growth conditions provided a stimulus for expression of genes in
the plasmid-encoded T4SS but did not affect expression of the
T4SS genes on chromosome 2. A mutation in the chromosome
2-encoded T4SS was shown not to contribute to bacterial per-
sistence or histopathology in the rat chronic respiratory infection
model (Bernier and Sokol, 2005). To date,no studies have observed
such a dramatic increase in expression of plasmid-encoded T4SS
genes suggesting that speciﬁc environmental signal(s) in the lung
environment enabled increased expression of these genes to be
detected. It was shown that the plasmid-encodedT4SS contributed
to onion tissuemaceration through secretion of one ormore effec-
tors (Engledow et al., 2004). Whether this plasmid-encoded T4SS
or its effectors have a role inmammalian cell/tissue damage has yet
to be determined.We observed some T6SS genes had lower in vivo
expression, in particular those genes on the BCAL0340 operon that
includes a gene encoding the secreted effector Hcp. Previous work
identiﬁed a transposon insertion in each of the three operons of
the T6SS locus affected survival of B. cenocepacia in the rat chronic
respiratory infection model (Hunt et al., 2004).
Using a mouse agar bead infection model, a ﬂagellin mutant
failed to cause mortality compared to wild type (Urban et al.,
2004). It was also shown that motility mutants were less able
to invade epithelial cells (Tomich et al., 2002). Recent work
showed expression of ﬂagellar- and chemotaxis-associated genes
and motility was reduced in B. cenocepacia strains of the ET12
lineage thatwere isolated fromCFpatients (Sass et al., 2011).How-
ever, a previous study showed transcription of ﬂagellar-associated
genes was increased in B. cenocepacia J2315 cultured in medium
supplemented with CF sputum (Drevinek et al., 2008). Con-
ﬂicting data regarding expression of ﬂagellar-associated genes
in these two studies likely reﬂect the experimental conditions
employed where increased expression of ﬂagellar-associated genes
was detected in rapidly growing cultures (Drevinek et al., 2008).
The phenotypic characteristics of the B. cenocepacia non-motile
CF isolates are similar to P. aeruginosa clinical isolates which
often acquire loss-of-function mutations associated with motility
during chronic lung infection (Mahenthiralingam et al., 1994).
It has also been shown that P. aeruginosa exhibited decreased
transcription of ﬂagellar-associated genes when cultured in CF
sputum (Wolfgang et al., 2004). In our study, we detected lower
in vivo expression of genes involved in motility and Flp type
pilus formation. This result was likely due to differences in cul-
ture conditions between in vitro and in vivo environments. The
agar bead infection model bypasses the colonization step dur-
ing infection (Cash et al., 1979). Our data suggest expression
of these genes is not required in an established infection taking
place in the lower respiratory tract. Therefore, decreased expres-
sion of these genes was expected since expression of these genes
is an energy-expensive process and is more likely associated with
rapidly growing cultures than cultures recovered from chronic
lung infection.
We identiﬁed numerous genes that were induced during lung
infections. Many of these genes encode proteins with functions
related to metabolism, physiology, or adaptation to a stressful
environment. While homologs of some of these proteins have
been studied in other pathogens, these proteins have not been
speciﬁcally studied in B. cenocepacia. Several B. cenocepacia ET12
lineage strains contain at least a 45-kb fragment of the plasmid
found in K56-2 and J2315 (Engledow et al., 2004) while strains
AU1054 and MCO-3 lack a plasmid (Winsor et al., 2008). While
plasmid-minus derivatives of B. cenocepacia J2315 or K56-2 have
not been reported, it would be interesting to determine what inﬂu-
ence absence of the plasmid may have on infection considering
the vast majority of plasmid-encoded genes were induced in vivo.
Further conﬁrmatory experiments are required to substantiate
trends for additional genes that exhibited altered expression in
the in vivo environmental conditions. Revealing the changes in
gene expression that occur in bacterial cells during infection is a
ﬁrst step in understanding the response of bacterial cells to the
host environment. Increased expression of genes during infection
suggests these genes promote bacterial survival and adaptation in
the lungs and potentially inﬂuence virulence. The identiﬁcation
of potential novel virulence genes among these in vivo induced
genes provides an opportunity to characterize these genes in more
detail in future studies. Determining what growth conditions alter
the expression of these genes and how they are regulated in B.
cenocepacia will shed light on their expression pattern. Increased
expression of genes during lung infection could be due to a change
in environmental cues that enable transcriptional activation by a
positive regulator(s) or derepression by a negative regulator(s).
For potentially novel virulence genes, it will be important to con-
struct mutations and examine their inﬂuence on virulence-related
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phenotypes and pathogenesis in one or more infection models.
This study provides an insight into B. cenocepacia gene expres-
sion in vivo and may provide opportunities to devise strategies to
reduce or control B. cenocepacia lung infections.
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APPENDIX
Table A1 | Burkholderia cenocepacia genes induced during chronic
lung infection.
Gene Annotation or predicted functiona Fold changeb
BCAL0123 Putative glycosyltransferase 2.17
BCAL0194 Putative oxidoreductase 1.62
BCAL0206A Putative outer membrane protein 2.36
BCAL0226 DNA-directed RNA polymerase beta
chain
1.73
BCAL0227 DNA-directed RNA polymerase beta’
chain
1.56
BCAL0269 Putative oxidoreductase 1.59
BCAL0278 Putative type IV pilus secretin 1.58
BCAL0290 Glutamate synthase small subunit 1.78
BCAL0292 2′,5′ RNA ligase family protein 1.66
BCAL0305 Putative exported protein 2.21
BCAL0366 Nitroreductase family protein 1.60
BCAL0403 Putative outer membrane-bound lytic
murein
1.54
BCAL0446 Putative aminotransferase 2.86
BCAL0580 Putative chromate transport protein 1.62
BCAL0623 Putative exported protein 1.72
BCAL0624 Putative outer membrane porin protein
precursor
1.62
BCAL0658 Allophanate hydrolase subunit 2 1.56
BCAL0668 Serine peptidase, family S9 unassigned 1.52
BCAL0704 d-alanyl-d-alanine carboxypeptidase 1.64
BCAL0804 Putative membrane protein 1.53
BCAL1103 Putative OsmB-like lipoprotein 2.13
BCAL1121 Hypothetical protein 1.65
BCAL1212 2-Oxoisovalerate dehydrogenase alpha
subunit
3.02
BCAL1213 2-Oxoisovalerate dehydrogenase beta
subunit
2.91
BCAL1214 Lipoamide acyltransferase
component of
3.68
BCAL1215 Dihydrolipoamide dehydrogenase 2.22
BCAL1226 Major facilitator superfamily protein 1.52
BCAL1279 Putative exported protein 1.64
BCAL1468 Putative electron transport protein 1.51
BCAL1499 Putative exported protein 1.79
BCAL1539 Putative exported protein 2.30
BCAL1657 Putative ribose transport system 1.77
BCAL1658 Putative ribose ABC transporter
ATP-binding
1.56
BCAL1671 Metallo peptidase, subfamily M23B 1.61
BCAL1678 Putative outer membrane usher protein
precursor
2.40
BCAL1699 Putative l-ornithine 5-monooxygenase 1.61
BCAL1715 Conserved hypothetical protein 1.53c
BCAL1749 Putative CoA-transferase 2.39
BCAL1750 Conserved hypothetical protein 2.39d
BCAL1751 Glyoxalase/bleomycin resistance 1.70
BCAL1754 Major facilitator superfamily protein 3.50
BCAL1783_J_0 TonB-dependent receptor (pseudogene) 1.59
Gene Annotation or predicted functiona Fold changeb
BCAL1789 Putative iron-transport protein 1.73
BCAL1798 Putative exported protein 1.95
BCAL1961 Putative exported protein 1.94
BCAL1980 Putative acyl-CoA synthetase 1.54
BCAL1992 Putative acyl-CoA thioesterase
precursor
2.00
BCAL2037 Putative ureidoglycolate hydrolase 1.61
BCAL2038 Putative allantoicase 1.53
BCAL2039 Putative uricase 1.72
BCAL2040 Polysaccharide deacetylase 1.54
BCAL2044 Muramoyltetrapeptide
carboxypeptidase
1.51
BCAL2083 Outer membrane protein assembly
factor YaeT
1.53
BCAL2155 Putative serine acetyltransferase 1.61
BCAL2179 Enolase 1.51
BCAL2187 Putative exported protein 1.56
BCAL2191 Putative membrane protein 3.09
BCAL2272 Conserved hypothetical protein 1.57d
BCAL2357 Ketol-acid reductoisomerase 1.59
BCAL2467 Putative lipoprotein 2.10
BCAL2468 Putative membrane protein 1.91
BCAL2475a Conserved hypothetical protein 1.63d
BCAL2476 Hypothetical protein 1.73
BCAL2482 Putative outer membrane protein 3.15
BCAL2485 Putative iron–sulfur cluster-binding
electron
2.12
BCAL2486 Putative iron–sulfur oxidoreductase 2.11
BCAL2488 Lysr family regulatory protein 2.07
BCAL2500 Hypothetical protein 1.67
BCAL2505 Putative membrane protein 1.55
BCAL2507 Conserved hypothetical protein 1.93c
BCAL2516 Hypothetical protein 1.70
BCAL2529 Putative transcriptional regulator 1.53
BCAL2541 Putative hydrolase 1.53
BCAL2552 Putative membrane protein 1.53
BCAL2553 Putative membrane protein 1.85
BCAL2558 Putative thioredoxin/FAD-dependent
pyridine
2.09
BCAL2588 Putative transposase (fragment) 1.81
BCAL2607 Putative exported protein 2.70
BCAL2615 Putative exported outer membrane
porin protein
2.16
BCAL2777 Putative N -acetylmuramoyl-l-alanine
amidase
1.58
BCAL2819 Putative permease protein 1.61
BCAL2911 Proline-rich exported protein 1.58
BCAL2956 Putative exported protein 1.52
BCAL3024 Putative exported protein 1.57
BCAL3033 Probable outer membrane lipoproteins
carrier
1.53
(Continued)
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Table A1 | Continued
Gene Annotation or predicted functiona Fold changeb
BCAL3038 ABC transporter ATP-binding
component
1.61
BCAL3039 ABC transporter, membrane permease 1.54
BCAL3040 ABC transporter, membrane permease 1.71
BCAL3041 Maltose-binding protein 2.09
BCAL3163 Putative nucleotidyltransferase 1.68
BCAL3203 Putative periplasmic TolB protein 1.64
BCAL3204 Putative OmpA family lipoprotein 1.68
BCAL3205 Putative exported protein 1.62
BCAL3289 Putative glycolate oxidase subunit GlcE 1.64
BCAL3297 Putative ferritin DPS-family
DNA-binding
1.67
BCAL3310 Putative exported protein 1.74
BCAL3311 Putative exported protein 1.60
BCAL3314 Putative membrane protein 2.43
BCAL3362 Putative oxidoreductase 1.77
BCAL3364 Putative gluconokinase 1.66
BCAL3473 Putative outer membrane porin 1.87
BCAL3486 Putative RNA polymerase sigma factor,
sigma-70
1.84
BCAL3490 Putative exported protein 1.96
BCAL3492 Putative exported protein 1.63
BCAM0027 PadR family regulatory protein 1.51
BCAM0042 Putative aldo/keto reductase 1.75
BCAM0047 Putative transporter – LysE family 2.57
BCAM0094 Xylulose kinase 1.67
BCAM0126 Putative AMP-binding enzyme 1.65
BCAM0166 NADH dehydrogenase 1.66
BCAM0178 Putative periplasmic solute-binding
protein
2.74
BCAM0195 Putative non-ribosomal peptide
synthetase
1.53
BCAM0207 Putative tyrosine-protein kinase 1.61
BCAM0235 Putative sodium bile acid symporter
family
1.51
BCAM0271 Conserved hypothetical protein 1.66d
BCAM0273 Conserved hypothetical protein 2.08d
BCAM0274a Hypothetical protein 1.95
BCAM0275 Conserved hypothetical protein 1.60d
BCAM0275a Conserved hypothetical protein 1.70d
BCAM0277 Conserved hypothetical protein 1.72c
BCAM0303 ABC transporter ATP-binding
membrane protein
1.62
BCAM0368 Putative branched-chain amino acid
transport
1.52
BCAM0414 Conserved hypothetical protein 2.01d
BCAM0415 Putative betaine aldehyde
dehydrogenase
1.53
BCAM0422 LuxR superfamily regulatory protein 1.89
BCAM0447 Putative exported multicopper oxidase 13.01
BCAM0459 Cysteine desulfurase 3.60
BCAM0478 Glucosamine – fructose-6-phosphate 1.52
Gene Annotation or predicted functiona Fold changeb
BCAM0502 Conserved hypothetical protein 1.78c
BCAM0595 LysR family regulatory protein 2.56
BCAM0630 Putative dehydrogenase 1.73
BCAM0676 Putative exported protein 1.84
BCAM0880 Putative methyltransferase 7.10
BCAM0895 Conserved hypothetical protein 1.55c
BCAM0926 Multidrug efﬂux system transporter
protein
5.89
BCAM0944 Putative lipoprotein 1.58
BCAM0983 3-Isopropylmalate dehydratase large
subunit
2.87
BCAM0983A Putative entericidin B-like bacteriolytic
toxin
2.01
BCAM0984 3-Isopropylmalate dehydratase small
subunit
2.08
BCAM0985 3-Isopropylmalate dehydrogenase 1.55
BCAM1016 Putative ribonuclease 1.81
BCAM1053 Putative reverse transcriptase – Group
II
1.72
BCAM1150 3-Hydroxyisobutyrate dehydrogenase 1.64
BCAM1151 Methylmalonate-semialdehyde
dehydrogenase
2.40
BCAM1171 Major facilitator superfamily protein 1.55
BCAM1187 TonB-dependent siderophore receptor 1.71
BCAM1207 ABC transporter ATP-binding
membrane protein
1.52
BCAM1263 Putative malate/l-lactate
dehydrogenase
1.79
BCAM1279 Conserved hypothetical protein 1.54d
BCAM1313 Putative amidase accessory protein 1.60
BCAM1315 Aliphatic amidase (acylamide
amidohydrolase)
1.55
BCAM1330 Putative polysaccharide export protein 1.73
BCAM1333 Putative exopolysaccharide
acyltransferase
1.56
BCAM1341 Conserved hypothetical protein 3.22c
BCAM1374 Conserved hypothetical protein 1.87c
BCAM1390 Putative aldolase 3.00
BCAM1425 Putative membrane protein 2.88
BCAM1427 LysE family transporter 3.76
BCAM1487 Putative ABC transporter,
substrate-binding
3.14
BCAM1488 Putative proline racemase 1.90
BCAM1527 Putative cation efﬂux protein 1.82
BCAM1563 ABC transporter ATP-binding
membrane protein
1.70
BCAM1679 Putative lysylphosphatidylglycerol
synthetase
1.62
BCAM1726 Putative exported protein 2.01
BCAM1742 Putative exported protein 1.87
BCAM1775 Putative transglycosylase associated
protein
1.76
(Continued)
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Table A1 | Continued
Gene Annotation or predicted functiona Fold changeb
BCAM1823 Putative methyltransferase 1.52
BCAM1901 Hypothetical phage protein 1.65
BCAM1904 Hypothetical phage protein 1.58
BCAM1911 Hypothetical phage protein 1.65
BCAM1946 Putative quinoxaline efﬂux system
transporter
1.61
BCAM1957 ABC transporter ATP-binding protein 1.56
BCAM1964 Putative exported protein 1.57
BCAM2007 TonB-dependent siderophore receptor 1.58
BCAM2025 Sigma-54 interacting regulatory protein 1.87
BCAM2051 Type III secretion system protein 1.73
BCAM2073 Putative exported protein 2.98
BCAM2095 Putative HTH transcriptional regulator 1.57
BCAM2096 Putative gamma-glutamylputrescine 1.87
BCAM2119 Carboxylesterase 1.81
BCAM2162 MarR family regulatory protein 1.99
BCAM2191 Enoyl-CoA hydratase/isomerase family 1.94
BCAM2192 Enoyl-CoA hydratase/isomerase family
protein
2.37
BCAM2193 Putative 3-hydroxyisobutyrate
dehydrogenase
2.39
BCAM2194 Methylmalonate-semialdehyde
dehydrogenase
2.26
BCAM2195 Putative AMP-binding enzyme 2.51
BCAM2196 Putative acyl-CoA dehydrogenase 2.10
BCAM2237 Putative 2,2-dialkylglycine
decarboxylase
2.41
BCAM2260 Major facilitator superfamily protein 1.61
BCAM2338 Putative glycosyltransferase 1.53
BCAM2356 Conserved hypothetical protein 1.63d
BCAM2453 Putative redoxin protein 1.69
BCAM2479 Putative transporter – LysE family 1.54
BCAM2488 Putative
phosphoglycerate/bisphosphoglycerate
1.56
BCAM2504 Conserved hypothetical protein 1.84c
BCAM2542 Fenitrothion hydrolase protein FedA 1.57
BCAM2618 Putative periplasmic 1.64
BCAM2623 Conserved hypothetical protein 2.05c
BCAM2647 Putative membrane protein 1.71
BCAM2648 NAD dependent
epimerase/dehydratase family
1.61
BCAM2685 Conserved hypothetical protein 2.11c
BCAM2700 Putative membrane protein 1.81
BCAM2701 Aconitate hydratase 1 2.66
BCAM2702 2-Methylcitrate synthase 5.88
BCAM2703 Probable methylisocitrate lyase 2.78
BCAM2730 Putative tripeptide permease 1.54
BCAS0028 Succinylglutamate
desuccinylase/aspartoacylase
2.80
BCAS0043 Putative l-lysine 6-monooxygenase 3.11
BCAS0050 Putative amidohydrolase 1.53
BCAS0053 FMN reductase 2.34
Gene Annotation or predicted functiona Fold changeb
BCAS0097 Putative cobalamin synthesis protein 1.66
BCAS0100 Putative ribokinase 1.52
BCAS0230 Putative sugar ABC transporter
ATP-binding
1.58
BCAS0251 Putative lipoprotein 1.61
BCAS0260 Conserved hypothetical protein 2.29d
BCAS0278 Tartrate dehydrogenase 1.66
BCAS0308 Putative ﬂp type pilus assembly protein 2.44
BCAS0362 Putative ketopantoate reductase 1.58
BCAS0397 Metallo peptidase, subfamily M20D 2.01
BCAS0436 AraC family regulatory protein 1.66
BCAS0443 Putative binding-protein-dependent
transport
5.32
BCAS0449 Putative binding-protein-dependent
transport
1.62
BCAS0461 Putative lipoprotein 3.69
BCAS0463 Putative membrane protein 1.64
BCAS0477 Putative lipoprotein 2.07
BCAS0482 Conserved hypothetical protein 4.89c
BCAS0513 Putative phage tail protein 1.54
BCAS0519 Hypothetical phage protein 1.64
BCAS0543 Putative phage transcriptional regulator 1.84
BCAS0545 Hypothetical phage protein 1.55
BCAS0547 Putative phage DNA-binding protein 1.54
BCAS0552 Hypothetical phage protein 1.72
BCAS0569 Conserved hypothetical protein 2.31d
BCAS0574 Amino acid ABC transporter
ATP-binding protein
3.67
BCAS0575 Putative binding-protein-dependent
transport
2.02
BCAS0577 Periplasmic solute-binding protein 1.54
BCAS0587_J_0 Aminopyrrolnitrin oxidase PrnD
(fragment)
2.33
BCAS0588 Putative membrane protein (fragment) 1.52
BCAS0672 Hypothetical protein 1.91
BCAS0713 Putative short-chain oxidoreductase 1.66
BCAS0730 Putative Na+ dependent nucleoside
transporter
2.13
BCAS0750 Putative exported protein 1.82
pBCA001 Putative partition protein 1.93
pBCA002 Putative partitioning protein 1.52
pBCA008 Conserved hypothetical protein 2.48d
pBCA009 Conserved hypothetical protein 1.74d
pBCA010 Putative membrane protein 3.19
pBCA012 Hypothetical protein 3.34
pBCA013 Putative exported protein 6.32
pBCA014 Putative membrane protein 3.28
pBCA015 Hypothetical protein 2.71
pBCA016 Conserved hypothetical protein 6.54d
pBCA017 Conserved hypothetical protein 3.24d
pBCA018 Hypothetical protein 8.91
pBCA019 Putative membrane protein 2.40
(Continued)
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Table A1 | Continued
Gene Annotation or predicted functiona Fold changeb
pBCA020 Putative TraG conjugative transfer
protein
5.51
pBCA021 Putative TraH conjugative transfer
protein
13.21
pBCA022 Conserved hypothetical protein 8.09c
pBCA023 Conserved hypothetical protein 5.09d
pBCA024 Conserved hypothetical protein 10.16c
pBCA025 Putative TraF conjugative transfer
protein
7.10
pBCA026 Putative membrane protein 10.57
pBCA027 Putative conjugative transfer protein
TraN
14.73
pBCA028 Conserved hypothetical protein 5.03d
pBCA029 Putative membrane protein 8.60
pBCA030 Putative conjugative transfer protein
TrbC
6.06
pBCA031 Putative TraU conjugative transfer
protein
6.92
pBCA032 Putative TraW conjugative transfer
protein
8.96
pBCA033 Putative peptidase protein 4.97
pBCA034 Putative membrane protein 6.01
pBCA035 GntR family regulatory protein 18.91
pBCA036 Putative membrane protein 13.82
pBCA037 Putative membrane protein 7.33
pBCA037a Hypothetical protein 11.90
pBCA038 Hypothetical protein 9.54
pBCA039 Hypothetical protein 1.98
pBCA040 Hypothetical protein 2.04
pBCA041 Putative TraC conjugative transfer
protein
9.20
pBCA042 Type IV secretion systemTraV 19.71
pBCA043 Thiol:disulﬁde interchange protein
DsbC
7.91
pBCA044 Putative TraB conjugative transfer
protein
3.00
Gene Annotation or predicted functiona Fold changeb
pBCA045 Putative exported protein TraK 12.43
pBCA046 Putative TraE conjugative transfer
protein
16.87
pBCA047 Type IV conjugative transfer system
protein TraL
46.07
pBCA048 Putative membrane protein 55.79
pBCA049 Putative transglycosylase protein 4.97
pBCA050 Hypothetical protein 8.74
pBCA051 LamB/YcsF family protein 159.40
pBCA052 Putative exported protein 789.20
pBCA053 Putative extracellular solute-binding
protein
480.70
pBCA054 LuxR family regulatory protein 3.90
pBCA056 Hypothetical protein 4.34
pBCA057 Putative conjugative transfer protein 4.80
pBCA058 Thiol:disulﬁde interchange protein
DsbD
7.43
pBCA059 Putative TraD conjugative transfer
protein
4.13
pBCA060 Hypothetical protein 6.97
pBCA062 Conserved hypothetical protein 2.52d
pBCA065 Conserved hypothetical protein 1.53c
pBCA076 Conserved hypothetical protein 1.55c
pBCA077 Conserved hypothetical protein 1.66d
pBCA087 NUDIX hydrolase family protein 1.53
pBCA088 Amidohydrolase family protein 1.64
pBCA090 Putative integrase 1.68
pBCA095 Putative ligase 1.59
aDerived from B. cenocepacia J2315 (Holden et al., 2009) at http://www.
burkholderia.com (Winsor et al., 2008) or http://www.microbesonline.org (Dehal
et al., 2009).
bFold change of RNA recovered from rat lungs (in vivo) relative to RNA isolated
from in vitro grown cultures as determined by microarray analysis.
cConserved hypothetical protein in one or more members of the Bcc and in B.
pseudomallei.
dConserved hypothetical protein in one or more members of the Bcc.
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Table A2 | Burkholderia cenocepacia genes induced during culture
in vitro.
Gene Annotation or predicted functiona Fold changeb
BCAL0046 Putative fatty-acid CoA ligase 1.56
BCAL0057 Putative membrane protein 2.17
BCAL0112 Conserved hypothetical protein 1.82
BCAL0113 B-type ﬂagellar hook-associated
protein 2
2.71
BCAL0114 Flagellin (type II) 8.29
BCAL0121 Aquaporin Z 3.29
BCAL0126 Chemotaxis protein MotA 2.19
BCAL0127 Chemotaxis protein MotB 2.03
BCAL0128 Chemotaxis two-component response
regulator
2.96
BCAL0129 Chemotaxis two-component sensor
kinase CheA
2.38
BCAL0130 Chemotaxis protein CheW 1.63
BCAL0132 Chemotaxis protein methyltransferase 2.52
BCAL0133 Putative chemoreceptor glutamine
deamidase cheD
2.47
BCAL0134 Chemotaxis response regulator
protein-glutamate
2.04
BCAL0135 Chemotaxis protein CheY 1.52
BCAL0136 Chemotaxis protein CheZ 2.09
BCAL0140 Flagellar biosynthetic protein FlhB 2.46
BCAL0143 Putative ﬂagellar biosynthesis protein 1.71
BCAL0147 5,10-Methylenetetrahydrofolate
reductase
2.17
BCAL0154 Histone-like nucleoid-structuring (H-NS) 1.97
BCAL0168 Hypothetical protein 2.50
BCAL0169 Conserved hypothetical protein 2.42
BCAL0179 Hypothetical protein 1.87
BCAL0203 Phosphatidylethanolamine-binding
protein
1.56
BCAL0212 Putative phenylacetic acid degradation
NADH
1.63
BCAL0233 30s Ribosomal protein S10 1.59
BCAL0339 Putative lipoprotein 1.60
BCAL0341 Conserved hypothetical protein 1.75
BCAL0342 Conserved hypothetical protein 1.68
BCAL0343 Conserved hypothetical protein 1.86
BCAL0344 Conserved hypothetical protein 1.58
BCAL0345 Conserved hypothetical protein 1.78
BCAL0356 Putative quinone oxidoreductase 1.51
BCAL0404 Phenylacetate-coenzyme A ligase 1.59
BCAL0406 Probable enoyl-CoA hydratase PaaG 1.56
BCAL0412 Conserved hypothetical protein
(pseudogene)
2.11
BCAL0413 Conserved hypothetical protein 1.67
BCAL0431 Conserved hypothetical protein 1.86
BCAL0432 Putative membrane protein 1.61
BCAL0434 Putative exported protein 2.13
BCAL0505 Integrase/recombinase 1.71
BCAL0511 Putative deoxygenases 1.60
Gene Annotation or predicted functiona Fold changeb
BCAL0514 Putative membrane protein 2.52
BCAL0522 Flagellum-speciﬁc ATP synthase FliI 1.84
BCAL0523 Flagellar assembly protein FliH 1.63
BCAL0527 Flagellar protein FliS 3.38
BCAL0528 Conserved hypothetical protein 2.80
BCAL0543 Major facilitator superfamily protein 1.64
BCAL0561 Flagella synthesis protein FlgN 1.94
BCAL0562 Negative regulator of ﬂagellin synthesis 2.56
BCAL0567 Flagellar hook protein 1 FlgE1 1.57
BCAL0568 Flagellar basal-body rod protein FlgF
(putative
1.66
BCAL0576 Flagellar hook-associated protein 1
(HAP1)
3.18
BCAL0577 Flagellar hook-associated protein 3
(HAP3)
3.20
BCAL0621 Putative cyclic-di-GMP signaling
protein
1.56
BCAL0705 Putative d-amino acid aminotransferase 1.55
BCAL0706 Conserved hypothetical protein 1.75
BCAL0744 Appr-1-p processing enzyme family
protein
1.74
BCAL0771 Non-heme chloroperoxidase 1.82
BCAL0808 P-loop ATPase protein family protein 1.88
BCAL0812 Sigma-54 modulation protein 1.91
BCAL0813 Putative RNA polymerase sigma-54
factor
2.13
BCAL0831 Putative storage protein 4.32
BCAL0833 Putative Acetoacetyl-CoA reductase 1.78
BCAL0834 Putative membrane protein 2.15
BCAL0842 Putative membrane protein 2.26
BCAL0928 Conserved hypothetical protein 3.58
BCAL0947 Putative membrane protein 1.55
BCAL1055 Histidine transport system permease
protein
1.74
BCAL1056 Histidine transport system permease
protein
1.81
BCAL1057 Histidine ABC transporter ATP-binding
protein
1.98
BCAL1058 AraC family regulatory protein 2.22
BCAL1059 Succinylornithine transaminase 1.81
BCAL1060 Putative arginine
N -succinyltransferase, alpha
1.63
BCAL1061 Putative arginine
N -succinyltransferase, beta
1.86
BCAL1062 Succinylglutamic semialdehyde
dehydrogenase
1.90
BCAL1063 Succinylarginine dihydrolase 2.58
BCAL1064 Putative succinylglutamate
desuccinylase
2.00
BCAL1065 Periplasmic solute-binding protein 1.91
BCAL1146 AraC family regulatory protein 1.73
(Continued)
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Table A2 | Continued
Gene Annotation or predicted functiona Fold changeb
BCAL1155 Putative maleate cis–trans isomerase 3.29
BCAL1159 Putative 2,3-dihydroxybenzoate-AMP
ligase
1.52
BCAL1167 Putative exported protein 1.74
BCAL1168 Conserved hypothetical protein 1.71
BCAL1221 Putative porin 1.54
BCAL1233 Putative heat shock Hsp20-related
protein
1.65
BCAL1273 Phosphate ABC transporter
ATP-binding protein
1.55
BCAL1282 Putative membrane protein 2.39
BCAL1291 Putative membrane protein 1.54
BCAL1292 Putative membrane protein 1.75
BCAL1299 Conserved hypothetical protein 1.51
BCAL1300 Conserved hypothetical protein 1.98
BCAL1316 Conserved hypothetical protein 1.56
BCAL1326 Conserved hypothetical protein 8.68
BCAL1357 Putative exported protein 1.56
BCAL1359 Conserved hypothetical protein 1.54
BCAL1360 Hypothetical protein 1.85
BCAL1373 LysR family regulatory protein 1.94
BCAL1390 Endoglucanase precursor 2.00
BCAL1394 Putative exported protein 1.51
BCAL1396 Putative membrane protein 1.72
BCAL1418 Major facilitator superfamily protein 2.31
BCAL1435 Inositol 2-dehydrogenase 2.41
BCAL1452 Putative methyl-accepting chemotaxis
protein
1.75
BCAL1525 Flp type pilus subunit 12.95
BCAL1525a Putative ﬂp type pilus leader peptidase 4.62
BCAL1526 Putative ﬂp type pilus assembly protein 2.62
BCAL1527 Flp type pilus assembly protein 2.05
BCAL1528 Flp type pilus assembly protein 2.87
BCAL1529 Flp pilus type assembly-related protein 1.93
BCAL1530 Flp pilus type assembly protein 3.56
BCAL1531 Flp type pilus assembly protein 2.02
BCAL1532 Flp type pilus assembly protein 2.40
BCAL1533 Putative lipoprotein 2.15
BCAL1534 Putative exported protein 2.81
BCAL1535 Putative membrane protein 1.71
BCAL1573 Hypothetical phage protein 1.52
BCAL1574 Hypothetical phage protein 1.56
BCAL1577 Hypothetical phage protein 2.26
BCAL1596 Hypothetical phage protein 1.66
BCAL1597 Hypothetical phage protein 1.78
BCAL1610 Periplasmic cystine-binding protein 1.59
BCAL1640 Major facilitator superfamily protein 3.38
BCAL1668 Periplasmic solute-binding protein 2.02
BCAL1677 Putative type-1 ﬁmbrial protein 1.74
BCAL1730 Precorrin-4 C11-methyltransferase 1.71
BCAL1775 Putative demethylase oxidoreductase 1.85
BCAL1791 Conserved hypothetical protein 2.23
Gene Annotation or predicted functiona Fold changeb
BCAL1818 Metallo-beta-lactamase superfamily
protein
1.52
BCAL1900 Thioredoxin 1.96
BCAL1913 Putative acetoin catabolism protein 1.64
BCAL1949 Glyoxylate carboligase 1.62
BCAL2027 Conserved hypothetical protein 2.11
BCAL2054 Putative HEAT-like repeat protein 2.58
BCAL2059 Putative 2′–5′ RNA ligase 1.81
BCAL2122 Malate synthase A 1.65
BCAL2143 Ubiquinol oxidase polypeptide I 1.59
BCAL2192 Conserved hypothetical protein 1.74
BCAL2193 Ferredoxin, 2Fe–2S 1.79
BCAL2197 Putative iron–sulfur cluster scaffold
protein
2.08
BCAL2198 Cysteine desulfurase 1.69
BCAL2208 Dihydrolipoamide acetyltransferase
component of
1.62
BCAL2210 Two-component regulatory system,
sensor kinase
1.56
BCAL2253 Conserved hypothetical protein 1.73
BCAL2254 Conserved hypothetical protein 1.56
BCAL2297 Conserved hypothetical protein 1.57
BCAL2305 Putative potassium channel subunit 1.75
BCAL2309 Putative copper-related MerR family
regulatory
1.52
BCAL2375 Putative membrane protein 1.79
BCAL2385 Methylglyoxal synthase 1.67
BCAL2479 Putative IstB-like ATP-binding protein 2.81
BCAL2494 Putative exported protein 53.57
BCAL2531 Hypothetical protein 1.56
BCAL2614 LysR family regulatory protein 6.70
BCAL2645 Putative OmpA family membrane
protein
1.66
BCAL2671 LysR family regulatory protein 1.74
BCAL2746 Putative citrate synthase 1.79
BCAL2751 Putative ketopantoate reductase 1.68
BCAL2775 Putative 4Fe–4S cluster-binding
ferredoxin
1.67
BCAL2792 Putative tryptophan 2,3-dioxygenase 1.70
BCAL2793 Major facilitator superfamily protein 1.68
BCAL2847 Putative methionine aminopeptidase 1.55
BCAL2904 Conserved hypothetical protein 3.85
BCAL2969 Hypothetical phage protein 1.56
BCAL2969a Hypothetical protein 1.68
BCAL2971 Hypothetical phage protein 1.55
BCAL2973 Putative exported protein 1.64
BCAL2998 Transglycosylase associated protein 2.82
BCAL3006 Cold shock-like protein 3.81
BCAL3018 Conserved hypothetical protein 2.19
BCAL3109 Urease accessory protein 1.69
BCAL3178 LysR family regulatory protein 1.72
BCAL3179 Probable d-lactate dehydrogenase 1.91
(Continued)
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BCAL3211 Conserved hypothetical protein 1.66
BCAL3227 Conserved hypothetical protein 2.10
BCAL3231 Hypothetical protein 1.63
BCAL3234 Glycosyltransferase 1.69
BCAL3239 Glucosyltransferase 1.84
BCAL3368 Putative regulatory protein 1.85
BCAL3427 Histone H1-like protein 2.68
BCAL3428 Ribonucleoside-diphosphate reductase
beta chain
1.58
BCAL3457 Cell division protein FtsZ 1.71
BCAM0010 2-Amino-3-ketobutyrate coenzyme A
ligase
2.03
BCAM0011 Threonine 3-dehydrogenase 1.71
BCAM0028 Putative FHA-domain protein 1.58
BCAM0030 Conserved hypothetical protein 8.45
BCAM0031 Conserved hypothetical protein 5.26
BCAM0032 Conserved hypothetical protein 1.71
BCAM0064 Conserved hypothetical protein 1.89
BCAM0067 Putative short-chain dehydrogenase 2.24
BCAM0069 Conserved hypothetical protein 1.57
BCAM0070 Putative hydrolase 1.66
BCAM0096 ABC transporter ATP-binding protein 2.32
BCAM0103 Major facilitator superfamily protein 1.65
BCAM0186 Lectin 2.64
BCAM0188 N -acyl-homoserine lactone dependent
regulatory
1.57
BCAM0190 Putative aminotransferase – class III 2.44
BCAM0191 Putative non-ribosomal peptide
synthetase
2.05
BCAM0192 Conserved hypothetical protein 1.65
BCAM0194 Conserved hypothetical protein 1.94
BCAM0210 Putative transferase 1.71
BCAM0288 Two-component regulatory system,
response
1.52
BCAM0446 Outer membrane efﬂux protein 187.90
BCAM0485 LacI family regulatory protein 4.99
BCAM0487 Conserved hypothetical 1.53
BCAM0504 CsbD-like protein 2.24
BCAM0505 Putative membrane-attached protein 1.67
BCAM0507 CsbD-like protein 2.40
BCAM0521 Putative IstB-like ATP-binding protein 2.85
BCAM0522 Putative integrase 1.76
BCAM0589 Conserved hypothetical protein 1.68
BCAM0622 Two-component regulatory system,
sensor kinase
1.58
BCAM0623 Two-component regulatory system,
response
1.62
BCAM0633 Conserved hypothetical protein 2.67
BCAM0634 Hypothetical protein 10.80
BCAM0717 Putative Gram-negative porin 2.44
BCAM0753 Putative membrane protein 2.18
BCAM0780 Putative helicase 1.59
Gene Annotation or predicted functiona Fold changeb
BCAM0851 Conserved hypothetical protein 1.83
BCAM0917 Putative DNA primase 1.64
BCAM0918 RNA polymerase sigma factor RpoD 1.52
BCAM0942 Putative exported protein 1.59
BCAM0953 Extracellular solute-binding protein 1.80
BCAM0957 Putative pepstatin-insensitive carboxyl 1.64
BCAM1041 Putative phage coiled coil domain
protein
2.06
BCAM1123 ABC transporter ATP-binding protein 1.52
BCAM1138 Major facilitator superfamily protein 1.77
BCAM1140 Putative aldehyde oxidase/xanthine 1.52
BCAM1141 Putative isochorismatase 1.81
BCAM1142 Conserved hypothetical protein 1.76
BCAM1143 Putative hydrolase 1.86
BCAM1144 Putative Asp/Glu/Hydantoin racemase 2.22
BCAM1146 Putative ﬂavoprotein monooxygenase 2.33
BCAM1147 Isoquinoline 1-oxidoreductase alpha
subunit
1.98
BCAM1164 Conserved hypothetical protein 1.87
BCAM1175 Putative iron–sulfur cluster protein 1.60
BCAM1213 Putative membrane protein 2.19
BCAM1255 Putative exported protein 1.88
BCAM1265 Putative amino acid permease 1.80
BCAM1316a Conserved hypothetical protein 2.00
BCAM1316b Conserved hypothetical protein 1.54
BCAM1335 Glycosyltransferase 1.52
BCAM1358 Gluconate 2-dehydrogenase
cytochrome c subunit
1.52
BCAM1411 Putative short-chain dehydrogenase 1.53
BCAM1412 Conserved hypothetical protein 10.28
BCAM1413A Conserved hypothetical protein 24.61
BCAM1414 Conserved hypothetical protein 3.86
BCAM1424 Methyl-accepting chemotaxis protein 1.68
BCAM1443 Putative exported protein 2.64
BCAM1473 Putative di-haem cytochrome c
peroxidase
1.67
BCAM1491 Putative exported protein 1.56
BCAM1572 Methyl-accepting chemotaxis protein 1.93
BCAM1573 Alpha, alpha-trehalose-phosphate
synthase
1.64
BCAM1588 Putative lyase 1.74
BCAM1602 Conserved hypothetical protein 1.59
BCAM1623 Thiolase 2.75
BCAM1643 AMP-binding protein 1.76
BCAM1704 2,3-Butanediol dehydrogenase 1.79
BCAM1710 Putative enoyl-CoA
hydratase/isomerase
1.58
BCAM1711 Phenylacetate-coenzyme A ligase 1.57
BCAM1733 Putative membrane protein 2.36
BCAM1734 Putative cytochrome c 1.73
BCAM1735 Putative oxidoreductase 1.89
BCAM1736 Conserved hypothetical protein 1.84
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BCAM1744 Serine peptidase, family S9 1.67
BCAM1777A Putative exported protein 4.61
BCAM1804 Methyl-accepting chemotaxis protein 2.10
BCAM1869 Conserved hypothetical protein 1.85
BCAM1871 Conserved hypothetical protein 2.64
BCAM1881 Hypothetical phage protein 1.86
BCAM1882 Hypothetical phage protein 1.80
BCAM1919 Hypothetical phage protein 2.12
BCAM1920 Hypothetical phage protein 1.90
BCAM1927 Putative exported protein 1.94
BCAM2021 Methyl-accepting chemotaxis protein 1.94
BCAM2024 Putative membrane protein 2.65
BCAM2048 Type III secretion ssytem protein 1.69
BCAM2052 Putative type III secretion system
protein
1.85
BCAM2053 Putative type III secretion system
protein
1.98
BCAM2067 Putative undecaprenyl pyrophosphate
synthetase
1.54
BCAM2087 Putative lipoprotein 2.24
BCAM2105 MerR family regulatory protein 1.64
BCAM2106 Non-heme chloroperoxidase 1.64
BCAM2167 Conserved hypothetical protein 1.51
BCAM2169 Putative outer membrane
autotransporter
1.73
BCAM2198 Serine peptidase, family S49 2.78
BCAM2199 Putative membrane protein 2.03
BCAM2207 Conserved hypothetical protein 1.90
BCAM2210 Putative membrane protein 2.59
BCAM2215 Putative copper resistance protein C
precursor
1.55
BCAM2307 Zinc metalloprotease ZmpB 2.28
BCAM2312 Putative ABC-type glycine betaine
transport
2.59
BCAM2321 Putative electron transfer ﬂavoprotein
alpha
1.74
BCAM2325 Putative dipeptidase 1.75
BCAM2333 Putative glutathione-independent
formaldehyde
1.73
BCAM2366 Putative proline iminopeptidase 1.57
BCAM2374 Putative methyl-accepting chemotaxis
protein
2.01
BCAM2377 Putative exported protein 3.99
BCAM2378 Putative Xaa-Pro dipeptidyl-peptidase 1.63
BCAM2403 Conserved hypothetical protein 1.97
BCAM2419 Putative outer membrane protein A
precursor
1.79
BCAM2444 Putative exported protein 2.52
BCAM2523 Conserved hypothetical protein 2.31
BCAM2545 Major facilitator superfamily protein 1.72
BCAM2563 Methyl-accepting chemotaxis protein 1.62
BCAM2564 Putative aerotaxis receptor 3.44
Gene Annotation or predicted functiona Fold changeb
BCAM2625 Conserved hypothetical protein 2.00
BCAM2640 Putative methyltransferase 1.75
BCAM2657 Putative exported protein 1.55
BCAM2670 Conserved hypothetical protein 2.03
BCAM2674 Putative cytochrome oxidase subunit I 1.88
BCAM2677 Putative membrane protein 1.76
BCAM2690 Putative thioesterase 1.71
BCAM2711 H-NS histone family protein 1.77
BCAM2712 Conserved hypothetical protein 1.57
BCAM2748 Putative sigma factor 1.53
BCAM2754 Putative ketoreductase 1.70
BCAM2771 Putative dihydrodipicolinate synthetase 1.61
BCAM2806 Putative sugar ABC transporter
ATP-binding
2.87
BCAM2837_J_0 Two-component regulatory system,
response
1.87
BCAM2837_J_1 Two-component regulatory system,
response
2.42
BCAS0018 MarR family regulatory protein 1.55
BCAS0040 Major facilitator superfamily protein 1.55
BCAS0074 Conserved hypothetical protein 1.52
BCAS0085 Organic hydroperoxide resistance
protein
1.53
BCAS0172 Putative dehydrogenase 1.51
BCAS0173 Putative tautomerase 1.60
BCAS0189 Conserved hypothetical protein 1.82
BCAS0190 Putative H-NS family DNA-binding
protein
2.38
BCAS0225 LysR family regulatory protein 2.71
BCAS0226 Putative hydrolase 1.99
BCAS0256 Putative porin protein 1.51
BCAS0263 Two-component regulatory system,
response
3.60
BCAS0264 Two-component regulatory system,
sensor kinase
2.41
BCAS0290 Conserved hypothetical protein 1.73
BCAS0291 Periplasmic solute-binding protein 2.74
BCAS0292 Conserved hypothetical protein 10.91
BCAS0293 Nematocidal protein AidA 51.98
BCAS0294 Putative GtrA-like family protein 3.06
BCAS0295 Glycosyltransferase 1.52
BCAS0299 Flp type pilus subunit 1.68
BCAS0399 Citrate-proton symporter 5.66
BCAS0400 Putative periplasmic solute-binding
protein
2.00
BCAS0403 Hypothetical protein 2.12
BCAS0406 Putative exported protein 1.64
BCAS0409 Zinc metalloprotease ZmpA 6.72
BCAS0452 Putative membrane protein 1.56
BCAS0462 Putative alpha-galactosidase 2.14
BCAS0467 Putative transcriptional
regulator – DeoR
1.67
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BCAS0481 Putative lipoprotein 1.86
BCAS0510 Hypothetical phage protein 2.29
BCAS0540 Hypothetical phage protein 1.72
BCAS0548 Hypothetical phage protein 1.69
BCAS0572 Putative exported protein 1.70
BCAS0573 Putative exported protein 1.72
BCAS0576 Putative binding-protein-dependent
transport
1.52
BCAS0579 Putative exported protein 2.01
BCAS0595 Putative sugar efﬂux transporter 1.53
BCAS0596 Conserved hypothetical protein 1.58
Gene Annotation or predicted functiona Fold changeb
BCAS0661C Hypothetical protein 1.83
BCAS0662 Conserved hypothetical protein 1.91
BCAS0669 Hypothetical protein 1.90
BCAS0700 Putative oxygen-insensitive NAD(P)H 1.52
BCAS0717 Hypothetical protein 2.26
BCAS0773 Putative exported protein 1.64
pBCA055 Putative membrane protein 18.16
aDerived from B. cenocepacia J2315 (Holden et al., 2009) at http://www.
burkholderia.com (Winsor et al., 2008) or http://www.microbesonline.org (Dehal
et al., 2009).
bFold change of RNA isolated from in vitro grown cultures relative to RNA
recovered from rat lungs (in vivo) as determined by microarray analysis.
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